Hanson Pharmaceuticals (002412.SZ): Simo soup oral solution approved for drug clinical trials

Zhitongcaijing · 11/09 10:57

Zhitong Finance App News, Hanson Pharmaceuticals (002412.SZ) issued an announcement. Recently, the company received approval from the State Drug Administration to issue a “Pharmaceutical Clinical Trial Approval Notice” to increase the function and treatment of Simotang oral liquid, and agreed to carry out clinical trials of this product for non-erosive reflux disease.